Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Discovery of new biological principle can give better cancer treatment

13.09.2004


Pioneering research on leukaemia cells can have identified their vulnerable spot. This new knowledge can now be used to produce more effective medicines.



A group of scientists at the University of Bergen and Haukeland University Hospital made a surprising discovery when they stimulated leukaemia cells with the growth hormone GM-CSF. The reaction of the cells surprised everyone and would seem to indicate that scientists in Bergen have uncovered a new biological principle and consequently, a new therapeutic goal.

"We shouted, and expected to get one reply, but what we got was a bellow from an entire football team," says Project Leader Bjørn Tore Gjertsen, who was recently presented in the renowned American periodical Cell.


Hugely important discovery for cancer patients

Cell membranes contain receptors that are stimulated by a number of environmental factors, among them hormones. This starts a chain reaction between proteins that can in cancer cells result in increased production of substances that hamper necrocytosis (cell death) and encourage cancer. A mutation in receptor Flt3 and how this activates the chain reaction has previously been paid a lot of attention. In the tests carried out by Gjertsen and his fellow scientists, it was the GM-CSF receptor that captured their attention. Patients with Flt3 mutation showed an enormous reaction, in proteins that should in principle be normal. This indicates that the attack should be mounted here, if one is to find effective but gentle methods of cancer treatment.

"We have used tests from thirty patients with an acute type of spinal leukaemia. Compared to young people with lymphatic leukaemia, these patients have little chance of recovery. Life expectancy without treatment is about 2-3 months and only 20 percent are cured by chemotherapy. The study results can in principle also be applied to other types of cancer cells, so these results can prove to be of great importance for future cancer sufferers," says Gjertsen.

In this particular research project, Gjertsen has collaborated with colleagues from Stanford University and also several from the research milieu in Bergen, including Randi Hovland and Øystein Bruserud. With support from the cancer association, Bruserud has over the last twelve years, collected an invaluable bank of leukaemia tests. The Americans were contacted because they have developed a quick method for looking at the activation of proteins with the help of an antibody produced by mice.

"We have invaluable profiles that give us a comprehensive picture of what happens inside the cells. In spite of the huge amount of scientific research on cancer during the last ten years, there have been few important clinical results. This is mainly due to the fact that we have turned one stone at a time and studied the building blocks of the cancer cells individually. In system biology we try to look for patterns so that we can get a complete and realistic overall picture," says Gjertsen, "and adds that the use of cells collected from patients, and not static cell lines, can be the only way to get secure results."

The collaboration now continues with unabated strength, searching for energized key cancer proteins that lie under the signal line studied in the Cell article.

Bjørn Tore Gjertsen | alfa
Further information:
http://www.helse-bergen.no
http://www.forskningsradet.no

More articles from Life Sciences:

nachricht Water forms 'spine of hydration' around DNA, group finds
26.05.2017 | Cornell University

nachricht How herpesviruses win the footrace against the immune system
26.05.2017 | Helmholtz-Zentrum für Infektionsforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>